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Available online xxxxObjective: The objectives of the study were to (1) map questions in epilepsy-specific patient-reported out-
come measures (PROMs) of children's health-related quality of life (HRQoL) to a proposed core outcome
set (COS) for childhood epilepsy research and (2) gain insight into the acceptability of two leading candi-
date PROMs.
Method:We identified 11 epilepsy-specific PROMs of children's HRQoL (17 questionnaire versions) in a pre-
vious systematic review. Each item from the PROMs was mapped to 38 discrete outcomes across 10 do-
mains of the COS: seizures, sleep, social functioning, mental health, cognition, physical functioning,
behavior, adverse events, family life, and global quality of life. We consulted with three children with epi-
lepsy and six parents of children with epilepsy in Patient Public Involvement and Engagement (PPIE) work
to gain an understanding of the acceptability of the two leading PROMs from our review of measurement
properties: Quality of Life in Childhood Epilepsy (QOLCE-55) and Health-Related Quality of Life Measure
for Children with Epilepsy (CHEQOL).
Results: Social Functioning is covered by all PROMs except DISABKIDS and G-QOLCE andMental Health is cov-
ered by all PROMs except G-QOLCE and Hague Restrictions in Childhood Epilepsy Scale (HARCES). Only two
PROMs (Epilepsy and Learning Disability Quality of Life (ELDQOL) and Glasgow Epilepsy Outcome Scale
(GEOS-YP)) have items that cover the Seizure domain. The QOLCE-55 includes items that cover the domains
of Physical Functioning, Social Functioning, Behavior, Mental Health, and Cognition. The CHEQOL parent and
child versions cover the same domains as QOLCE-55 except for Physical Functioning and Behavior, and the
child version has one item that covers the discrete outcome ofOverall Quality of Life and one item that covers
the discrete outcome of Relationship with parents and siblings. The QOLCE-55 parent version was acceptable
to the parents we consulted with, and CHEQOL parent and child versions were described as acceptable to
our child and parent advisory panel members.
Significance: Mapping items from existing epilepsy-specific PROMs for children is an important step in
operationalizing our COS for childhood epilepsy research, alongside evaluation of their measurement prop-
erties. Two leading PROMS, QOLCE-55 and CHEQOL, cover a wide range of domains from our COS and would
likely be used in conjunction with assessment tools selected for specific study objectives. The PPIE work
provided practical insights into the administration and acceptability of candidate PROMs in appropriate
context. We promote our COS as a framework for selecting outcomes and PROMs for future childhood
epilepsy evaluative research.
© 2020 The Author(s). Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).Keywords:
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nc. This is an open access article und1. Introduction
Epilepsy is defined by the tendency for recurrent seizures [1] and
covers a range of different age-related clinical syndromes ander the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
2 H. Crudgington et al. / Epilepsy & Behavior 112 (2020) 107372etiologies. In children, epilepsy is the most common, chronic, neuro-
logical condition, affecting around 3.2/1000 in Europe [2,3]. Much of
its impact is due to the medical, psychological, social, and cognitive
implications of seizures and antiepileptic medications [4–6] and con-
sequently, health-related quality of life (HRQoL) has become an im-
portant emphasis for childhood epilepsy research. Health-related
quality of life can be assessed using patient-reported outcome mea-
sures (PROMs). However, PROMs cannot simply be selected “off-
the-shelf”. Evidence of robust measurement properties is important,
and also, the salience and acceptability of items to people completing
the questionnaires must also be considered [7].
When choosing a childhood epilepsy PROM for a specific objective,
essential properties to consider, in addition to validity and reliability, in-
clude how well items map onto aspects of health; how the questions
and response options are received by the respondents; and the impor-
tance of the items to children with epilepsy and their families. Previ-
ously, Sadeghi et al. [8] mapped epilepsy-specific PROMs for children
to domains in the World Health Organization's International Classifica-
tion of Functioning, Disability and Health for Children and Youth (ICF-
CY) [8,9]. Although the ICF-CY is a comprehensive classification system
of health for children, its domains are not specific to epilepsy and do not
classify broader aspects of wellbeing and quality of life. Therefore, it is
important to evaluate how PROMs of interest map to all the outcomes
perceived as more important for children with epilepsy, — and this
has not previously been done.
We have proposed a core outcome set (COS) for childhood epi-
lepsy research [10,11]. Our COS development was uniquely child-
and family-centered, involving iterative Delphi surveys, and a face-
to-face meeting with young people with epilepsy, parents, and
health professionals. Stakeholders reached consensus on 38 out-
comes across ten health domains: (1) Seizures, (2) Sleep, (3) Physical
functioning, (4) Social functioning, (5) Behavior, (6) Mental Health,
(7) Cognition, (8) Family functioning, (9) Adverse events, and (10)
Global quality of life. Our COS captured commonly reported out-
comes such as ‘seizure frequency’ that are consistent with existing
tools such as the National Institute of Neurological Disorders and
Stroke (NINDS) Common Data Elements [12–15]. However, our COS
also highlights nonseizure-related, child-centered outcomes includ-
ing “feelings about epilepsy” (emotions or reactions to having epi-
lepsy such as embarrassment or stigma), which suggests that the
seizure-focused view is not the only important outcome for HRQoL
in young people with epilepsy. Therefore, our COS is unique in its
representation of stakeholders' views.
The next stage of the COS development work is to establish how
to measure the core outcomes [16]. One approach would be to con-
duct systematic reviews within each of the ten health domains,
though the resulting battery of measures might be burdensome for
respondents and would have required more resources than available
to us. Therefore, we took a pragmatic approach to map the content of
11 epilepsy-specific PROMs for children to our COS, using a broadly
similar method by which PROM questions have been mapped to
the ICF-CY [8].
Subsequently, we focused on two leading candidate PROMs with
better evidence of robust measurement properties from our prior
systematic review [17]: Quality of Life in Childhood Epilepsy 55-
item version (QOLCE-55) parent report and the Health-Related Qual-
ity of Life Measure for Children with Epilepsy (CHEQOL) child and
parent report [18,19]. The QOLCE-55 is part of the QOLCE family of
PROMs, which has four questionnaire versions with different num-
bers of items (QOLCE 76, QOLCE-55, QOLCE-16, and G-QOLCE)
[19–25]. Both QOLCE and CHEQOL have been used internationally
for numerous evaluative studies and have been translated into
other languages for use [26–51]. We consulted our Patient Public In-
volvement and Engagement (PPIE) Research Advisory Panel of chil-
dren with epilepsy and their parents on the acceptability of the two
leading PROMs.2. Methods
2.1. Epilepsy-specific PROMs
Our previous systematic review identified 11 epilepsy-specific
PROMs of children's HRQoL (Table 1). Two PROMs have parent and
child report versions with slightly different items (Quality of Life in Pe-
diatric Epilepsy (QOLPES) and CHEQOL); the Impact of Childhood Illness
Scale (ICI; parent-only report) was developed from a prior question-
naire version (Modified Impact of Epilepsy Schedule (MIOES)); and
theQOLCE (parent-only report) family of PROMs has four questionnaire
versions with differing numbers of items (G-QOLCE, QOLCE-16, QOLCE-
55, QOLCE-76). The different versions result in 17 questionnaires tomap
(Table 1), and so we use the term ‘questionnaire’ from here onwards to
reflect this. Sadeghi et al. [8] found thirteen epilepsy-specific PROMs for
children in their review, andwe identified nine of the same PROMs. The
PROMs that we did not include from the Sadeghi et al. [8] review were
the Epilepsy Foundation of America Concerns Index (EFA), the Glasgow
Epilepsy Outcome Scale (GEOS-C), The Impact of Childhood Neurologic
Disability Scale (ICNDS), and the Epilepsy and Children Questionnaire
(ECQ). We did not include the EFA and GEOS-C as they are PROMs for
adults. The ICNDS is not condition-specific butmay be useful in epilepsy.
The ECQ was validated in an Italian population. We found two further
PROMs that were the GEOS-YP (child-only report) and Pediatric Quality
of Life Inventory™ EpilepsyModule (PedsQL™ EpilepsyModule) (parent
and child report).
2.2. Mapping
Mapping refers to the process of deciding where the content of a
PROM fits in relation to a specific framework. Two reviewers (HC and
AC) collaboratively discussed and mapped the 17 questionnaires to
our COS outcomes and definitions, item-by-item (Table 2; supple-
mentary 1). Wemapped items that did not match a discrete outcome
definition but broadly covered a domain area to one of the 10 COS
domains (Table 2). We excluded items that did not fit the COS or
were too broad. For example, we excluded the items that asked
about ‘general health’ from the QOLIE-AD-48 questionnaire as this
is not covered in our COS. Similarly, we excluded the item ‘In the
past 4 weeks, how often have these problems (physical or emo-
tional) caused you to do fewer things than you would have liked to
do?’ because ‘fewer things than you would have liked to do’ is too
broad and not within the conceptual framework of our COS. Dis-
agreements about where an item should be mapped were arbitrated
by a third reviewer (CM).
2.3. Patient, Public Involvement and Engagement (PPIE)
INVOLVE, an organization funded by the National Institute of Health
Research (NIHR) in the UK, defines PPIE as “research being carried out
‘with’ or ‘by’ members of the public and patients rather than ‘to’, or
‘about’, or ‘for’ them” [52]. Patient and Public Involvement and Engage-
ment involves patients as active partners in research and can lead to
greater quality and relevance of research due to the unique patient per-
spective that PPIE members can bring. It can refer to a diverse range of
activities including consulting Advisory Panels of patients and the pub-
lic. This study is reported in line with the GRIPP2 short form for PPIE
(supplementary 2) [53]. We consulted with a subset of members from
our established Advisory Panel, consisting of children with epilepsy
and parents, about the two leading candidate questionnaires from our
systematic review [17], QOLCE-55 and CHEQOL. The members of our
Advisory Panel responded to a call through national epilepsy charities
and clinical services for people with experience of childhood epilepsy
to join our Advisory Panel. The aim of our Advisory Panel consultation
was to help further gain insight into the acceptability of the PROMs as
well as to assess their real-life functionality such as the speed of
Table 1
Epilepsy-specific patient reported outcome measures (PROMs) of children's HRQoL.
No. Instrument
version
Author Purpose No. of items and domains Age range Country/Origin Respondent
1a Adult's
Attitudes to
Children with
Epilepsy: Visual
Analogue Scale
Hoare (1986) [58] Assess adult's attitudes to children
with epilepsy
47 items, 7 domains: Physical
consequences of a single fit;
Etiology of epilepsy; Problems for
the child at present and in the
future; Side effects of drugs;
Problems for the child's parents;
Social restrictions or the child and
his family; Adverse effects of
family life
10 Edinburgh, UK Parent
1b Modified
Impact of
Epilepsy
Schedule
Hoare (1993) [59] Assess adult's attitudes to children
with epilepsy and the impact on
adults
39 items, 3 domains: The medical
care and treatment of epilepsy;
The child's adjustment and
development; Effects on family
life
5–15 years Edinburgh, UK Parent
1c The Impact of
Childhood
Illness Scale
(ICI)
Hoare et al.,
(2000) [57]
Assess the impact of
epilepsy/long-standing childhood
illness on QoL on the child and
family
30 items, 4 domains: impact on
the child's development and
adjustment; impact on the
parents; and impact on the family
and a combined total score. The
instrument is scored on two
dimensions: Frequency and
Importance.
6–17 years Edinburgh, UK Parent
2 The Hague
Restrictions in
Childhood
Epilepsy Scale
(HARCES)
Carpay et al.,
(1997) [61]
Quantify restrictions due to
disability in childhood epilepsy
10 items, including 2 global items 4–16 years Hague, Rotterdam Parent
3 Quality of Life in
Epilepsy
Inventory for
Adolescents
(QOLIE-AD-48)
Cramer et al.,
(1999) [62]
Assess HRQoL in adolescents with
epilepsy
48 items, 8 domains: Epilepsy
impact; Memory/concentration;
Attitudes towards epilepsy;
Physical functioning; Stigma;
Social support; School behavior;
Health perceptions and a total
summary score.
11–17
years
USA & Canada Child
4 Quality of Life in
Pediatric
Epilepsy
(QOLPES)
Arunkumar et al.,
(2000) [63]
To assess HRQoL in children with
epilepsy
20 items 3
months –
18 years
USA Parent & child
5a Quality of Life in
Childhood
Epilepsy
(QOLCE)
Sabaz et al.,
(2000) [20] &
Sabaz et al.,
(2003) [21]
Assess HRQoL for children with
epilepsy
Australian version:
73 items, 16 subscales, covering 7
domains: cognition, physical
activities, social activities,
emotional wellbeing, behavior,
general health, general quality of
life and a total score
USA version:
76 items, 16 subscales, covering 7
domains: cognition, physical
activities, social activities,
emotional wellbeing, behavior,
general health, general quality of
life and a total score
4–18 years New South Wales,
Australia
& USA
Parent
5b QOLCE 55 Goodwin et al.,
(2015) [19]
Assess HRQoL for children with
epilepsy, in a shortened version
55 items, 4 domains: Cognitive;
Emotional; Social and Physical
4–18-years Canada Parent
5c QOLCE 16 Goodwin et al.,
(2018) [25].
Assess HRQoL for children with
epilepsy, in a shortened version
16 items, 4 domains: Cognitive;
Emotional; Social and Physical
4–18-years Canada Parent
5d G-QOLCE Conway et al.,
(2018) [24].
Assess HRQoL for children with
epilepsy with 1-item
1 item 4–18 years Canada Parent
6 Impact of
Pediatric
Epilepsy Scale
(IPES)
Camfield et al.,
(2001) [64]
Assess the influence of epilepsy on
the major aspects of the family and
child's life
11 items 2–16 years Canada Parent
7 Health-Related
Quality of Life
Measure for
Children with
Epilepsy
(CHEQOL-25)
Ronen et al.,
(2003) [18].
Measure the HRQOL of
preadolescent children with
epilepsy
25 items, 5 domains:
Interpersonal/Social
Consequences; Worries and
Concerns; Intrapersonal/Emotional
Issues; Epilepsy My Secret and
Quest for Normality
6–15 years Canada Parent & child
8 DISABKIDS
(Epilepsy
Module)
Baars et al.,
(2005) [65]
Assess the HRQoL of children and
adolescents with epilepsy and their
families
10 items, 2 domains: Impact and
Social
4–16 years Collaboration of seven
European countries
(Austria, France,
Germany, Greece, the
Child and
parent report
(parent proxy
for 4–7-year
(continued on next page)
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Table 1 (continued)
No. Instrument
version
Author Purpose No. of items and domains Age range Country/Origin Respondent
Netherlands, Sweden
and the United
Kingdom)
olds)
9 Epilepsy and
Learning
Disability
Quality of Life
(ELDQOL)
Buck et al., (2007)
[66]
Assess HRQoL in children with both
epilepsy and learning disabilities
70 items, 4 domains: Behavior;
Seizure severity; Mood and Side
effects
2–18 years UK Parent
10 Glasgow
Epilepsy
Outcome Scale
(GEOS-YP)
Townshend et al.,
(2008) [67]
Assess the impact of epilepsy on an
adolescent's QoL that is based on
exploration of adolescent's views
50 items, 9 domains: Peer
Acceptance; School/work;
Development of Autonomy;
Future focus; Epilepsy as part of
Me; Medication issues; Seizures,
Knowledge about Epilepsy; Sense
of Uncertainty
10–18
years
Glasgow, UK
Tertiary epilepsy centers
Child
11 PedsQL Epilepsy
Module
Follansbee-Junger
et al., (2016) [68]
Validate a brief and reliable
epilepsy-specific, health-related
quality of life (HRQOL) measure in
children with various seizure types,
treatments, and demographic
characteristics.
29 items, 5 domains: Impact;
Cognitive; Sleep; Executive
Function and Mood/Behavior
2–18 years USA Parent only
report
(2–4-year
olds), and child
and parent
proxy report
(aged 5–18)
4 H. Crudgington et al. / Epilepsy & Behavior 112 (2020) 107372completion. This was not qualitative research [54] but was aimed at im-
proving the quality and relevance of our research.
Two Family Engagement Officers (SL and RM), respectively based in
the South East andNorth of England led the PPIE consultation.Members
of our Advisory Panel were invited to provide their personal views on
the PROMs. We adopted a structured approach using clear guidance
and simple feedback forms that asked questions on the length of time
taken to complete the questionnaire and the acceptability of the items
and response options. Advisory Panel members provided feedback via
email, post, or face-to-face and were offered reimbursement for their
time following payment guidance from INVOLVE [55].
Six parents of children with epilepsy from the Advisory Panel pro-
vided feedback on the CHEQOL parent version and QOLCE-55. Three
parents attended a face-to-face meeting held at a venue in Central
London facilitated by a FEO (SL). Three parents returned feedback via
post/email. Three children with epilepsy aged 12 to 15 from the Advi-
sory Panel provided feedback on theCHEQOL child version and returned
their feedback forms through email. The parents and children who
assisted with this work are from locations across the UK, white British
and English-speaking, and have a range of experience of childhood
epilepsy.
Ethics approval and formal consent is not appropriate or required for
PPIE as the people are involved as partners in the research not as
participants.
3. Results
3.1. Mapping
We mapped items from each epilepsy-specific PROM of children's
HRQoL to our COS of 38 outcomes across 10 domains (Tables 3 and 4).
Mapping each PROM item-by-item to our COS was not straightforward.
Some PROMs had items that could map to multiple aspects of the COS
(Table 2). Some of the more difficult PROMs to map included the ICI
[56,57]. The ICI was developed by merging two prior scales, the Adult
Attitudes To Children With Epilepsy (AATCWE) and the MIOES
[58,59]. We did not map the items of the AATCWE as it does not mea-
sure a child's HRQoL at a moment in time but instead asks questions
about hypothetical situations and the respondent's general attitudes.
The ICI was developed from items in the AATCWI and the MIOES. The
ICI has two scoring options of ‘frequency’ and ‘importance’. The two
scoring options meant that each item could map to a specific discreteoutcome but also be mapped to the discrete outcome of parental health
because every item was to be rated on an ‘importance’ scale to the
parent, regardless of the frequency.
3.1.1. Seizures domain
Two questionnaires (Epilepsy and Learning Disability Quality of Life
(ELDQOL) and GEOS-YP) cover the Seizure domain. The GEOS-YP
has four items that cover Seizures, while ELDQOLhas one item that covers
Seizures and 13 items that cover the discrete outcome of Seizure Severity.
3.1.2. Sleep domain
Both ELDQOL and PEDSQL are the only questionnaires that cover the
Sleep domain. The ELDQOL has one item that broadly covers Sleep. The
PEDSQL covers the broad domain of Sleep but also contains two items
that cover the discrete outcomes of Awakenings from Sleep and Daytime
Sleepiness.
3.1.3. Physical Functioning domain
More than half of the questionnaires (Hague Restrictions in Child-
hood Epilepsy Scale (HARCES), QOLIE-AD-48, QOLPES Parent and
child, QOLCE-76, QOLCE-55, QOLCE-16, ELDQOL, GEOS-YP, and PEDSQL)
broadly capture Physical functioning. Only ELDQOL captures the two dis-
crete outcomes within the Physical Functioning domain of Gross Motor
Function and Fine Motor Function.
3.1.4. Social Functioning domain
Fifteen questionnaires (not DISABKIDS and G-QOLCE) have items
that capture an aspect of Social functioning. The QOLCE-76 is the only
PROM that also covers all four discrete outcomeswithin the Social Func-
tioning domain. The ELDQOL has only one item that covers Ability to join
activities with others, and the PEDSQL has only one item that covers the
broad domain of Social Functioning.
3.1.5. Behavior domain
Seven questionnaires measure at least one aspect of Behavior
(MIOES, QOLIE-AD-48, QOLPES parent, QOLCE-76, QOLCE-55, ELDQOL,
PEDSQL). Four questionnaires measure the discrete outcome of Behav-
ioral Concerns (MIOES, QOLPES parent, QOLCE-76, QOLCE-55), and
only two questionnaires measure the discrete outcome of Impulsivity
(PEDSQL and QOLCE-76). The QOLCE-76 is the only questionnaire that
has items that cover the main domain of Behavior but also measures
the two discrete outcomes of Behavioral concerns and Impulsivity.
Table 2
Core outcome set (COS) for childhood epilepsy research.
Outcome Description Domain
Seizure freedom Not having seizures SEIZURES
Seizure frequency How often seizures occur
Seizure duration How long a seizure lasts
Seizure severity How bad seizures are in terms of effects on the person during and after seizures— such as falls or injuries,
incontinence, confusion, and time to recover afterwards
Total time spent asleep at night Total time spent asleep each night SLEEP
Total time spent asleep in 24 h Total time spent asleep in 24 h
Awakening from sleep Wakings in the night that parents/carers are aware of
Breathing difficulties May include snoring or gasping for breath
Daytime sleepiness Feeling sleepy or actually sleeping during the day
Movement ability – Gross motor function Using parts of the body together and efficiently, such as to ride a bike, or stand on one leg, catching and
throwing
PHYSICAL
FUNCTIONING
Manual ability – fine motor function Dexterity in handling objects, handwriting
Ability to join in activities with others Joining in with people, such as playing out with
friends, doing sports, joining in things
SOCIAL
FUNCTIONING
Friendships Forming and maintaining friendships
Engagement in school life Feeling part of the school community
Experience of other people's attitudes towards
epilepsy
Bullying, social exclusion
Behavioral concerns Being able to control emotions and respond to situations in context BEHAVIOR
Impulsivity Acting without thinking
Feelings about having epilepsy Emotions or reactions to having epilepsy, such as embarrassment, shame, stigma MENTAL
HEALTHSelf-esteem Overall feelings about yourself
Self-harm Thinking about hurting yourself on purpose or wishing you were dead
Fears of having a seizure Having a seizure in public, being injured during a seizure, dying during a seizure, what other people will
do during a seizure
Mood swings Quick unexplained changes of mood
Concealment Not telling people about epilepsy
Learning Gaining new skills & knowledge generally COGNITION
Literacy Reading, writing, spelling
Speech & Language Making yourself understood and understanding when spoken to
Memory Short & long term
School attendance Being and engaging in school curriculum
Academic attainment Reaching personal potential through studying and completing assigned tasks and projects, and
advancing to next stages of education
Concentration Focusing on something for the required period of time
Executive functioning The ability to plan and organize activities. Executive functions help you manage life tasks of all types. For
example, executive functions let you organize a trip, a research project, or a paper for school effectively
Relationships with parents & siblings Getting along well with and feeling close to other members of family FAMILY
FUNCTIONINGFamily life Impact of epilepsy on family life such as parent work opportunities and/or leisure time
Parental health Parent's physical and emotional wellbeing
Epilepsy specific attendance at A&E and/or
unplanned admission to the ward
Visiting the hospital due to an acute medical emergency ADVERSE
EVENTS
Adverse events or reactions Any unintended effects of treatments, side effects
Drug treatment failure events (adverse events or
poor seizure control)
Stopping medication because it's not working or causing problems
Overall quality of life How you feel your life is generally GLOBAL
QUALITY OF
LIFE
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Fifteen questionnaires (not G-QOLCE or HARCES) have items that
cover Mental health as a broad domain. The QOLCE-76 has 17 items
that measureMental Health broadly, three items that cover the discrete
outcome of self-esteem specifically and one item that covers self-harm.
The QOLCE-55 has seven items that cover Mental Health broadly and
two items thatmeasure thediscrete outcomeof self-esteem. The CHEQOL
child report has six items that broadly cover Mental Health and two
items that cover the discrete outcome of Feelings about having epilepsy.
3.1.7. Cognition domain
Fourteen questionnaires (not HARCES, G-QOLCE, or DISAKBIDS)
broadly cover Cognition. Memory and Concentration are the two dis-
crete outcomes measured most frequently with QOLCE-76 and
QOLCE-55 having six items each specifically measuring Memory,
and 4 items each specifically measuring Concentration.
3.1.8. Family Functioning domain
Nine questionnaires cover some aspect of Family Functioning
(MIOES, ICI, QOLIE-AD-48, QOLPES parent and child version, QOLCE-76, IPES, CHEQOL child, and ELDQOL). Every item in the MIOES and ICI
cover Parental health due to the way the PROM response items are
phrased around parental concern. In the ICI, there are two scales of Fre-
quency and Importance, which ask about the impact of all these ques-
tions on parent health.
3.1.9. Adverse events domain
Three questionnaires (ICI, ELDQOL, and GEOS-YP) have at least one
item that covers Adverse events or reactions.
3.1.10. Global Quality of Life domain
Seven questionnaires include one item that measures Global Quality
of Life (QOLPES child and parent, G-QOLCE, QOLCE-76, IPES, CHEQOL
child, and ELDQOL).
3.2. PPIE consultation on the acceptability of two leading candidate PROMs
3.2.1. QOLCE-55
The QOLCE-55 is a parent-report questionnaire for young people
with epilepsy aged between 4 and 18 years old with 55 items split
Table 3
Number of items from 11 epilepsy-specific PROMs for children represented in a proposed core outcome set for childhood epilepsy.
1a.
MIoES
1b.
ICI
2.
HARCES
3.
QOLIE-AD-48
4a.
QOLPES
(Parent)
4b.
QOLPES
(Child)
5a.
G-QOLCE
5b.
QOLCE-76
5c.
QOLCE-55
5d.
QOLCE-16
6.
IPES
7a.
CHEQOL
(child)
7b.
CHEQOL
(parent)
8.
DISABKIDs
9.
ELDQOL
10.
GEOS-YP
11.
PEDSQL
SEIZURES (total) 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14 4 0
Seizure freedom
Seizure frequency
Seizure duration
Seizure severity 13
General seizures 1 4
SLEEP (total) 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 3
Total time spent asleep at night
Total time spent asleep in 24 h
Awakenings from sleep 1
Breathing difficulties
Daytime sleepiness 1
General sleep 1 1
PHYSICAL FUNCTIONING (total) 0 0 4 4 1 1 0 9 5 3 0 0 0 0 3 1 1
Movement ability – Gross motor function 1 1
Manual ability – fine motor function 2
General Physical Functioning 4 4 1 1 8 5 3 1 1
SOCIAL FUNCTI
ONING (total)
2 2 3 2 2 2 0 9 8 4 2 7 4 0 1 6 1
Ability to join activities with others 2 2 3 1
Friendships 2 1 1 1 1 1 1 1 1
Engagement in school life 1 1 2 1 1
Experience of other people's attitudes towards
epilepsy
1 1 1 1 1 1 4 2 5
General Social Functioning 2 1 4 2 2 1 1 1
BEHAVIOR (total) 3 0 0 2 1 0 0 8 6 0 0 0 0 0 1 0 2
Behavioral concerns 2 1 3 3
Impulsivity 1 1
General Behavior 1 2 4 3 1 1
MENTAL HEALTH (total) 2 2 0 13 1 5 0 18 9 4 1 10 9 10 1 13 8
Feelings about having epilepsy 1 6 2 2 1 6 6 2
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Self-esteem 6 1 1 2 1 1
Self-harm 1
Fears of having a seizure 2 1 2 4 4 1
Mood swings 2 1
Concealment 1 1 1
General Mental Health 1 1 16 7 4 6 5 1 1 5
COGNITION (total) 3 2 0 12 2 3 0 20 22 4 1 2 2 0 3 2 6
Learning 1
Literacy 1 1 1 1
Speech & language 2 3 2 1
Memory 1 1 6 6 1 1 1 1
School attendance 2 1
Academic attainment 1 1 1 1
Concentration 1 2 1 1 4 4 1 1 1 1
Executive functioning 2 2 2 1
General Cognition 1 2 2 1 4 7 3 1 1
FAMILY FUNCTIONING (total) 19 8 0 1 5 1 0 1 0 0 4 1 0 0 4 0 0
Relationships with parents and siblings 1 1 2 1 1
Family life 6 5 1 1
Parental health 7b 1a 4 1 2
General Family Functioning 6 2 1 1
ADVERSE EVENTS (total) 0 2 0 0 0 0 0 0 0 0 0 0 0 0 2 1 0
Epilepsy specific attendance at A&E and/or
unplanned admission to the ward
Adverse events or reactions 2 2 1
Drug treatment failure events (adverse events or
poor seizure control)
General Adverse Events
GLOBAL QUALITY OF LIFE (total) 0 0 0 0 1 1 1 1 0 0 1 1 0 0 1 0 0
Overall quality of life 1 1 1 1 1 1 1
Too broad/vague 1 1 7 1 4 1 5 3
Do not fit the COS: 10 13 2 7 6 3 9 1 2 4 10 10 18 7
1a. Modified Impact of Epilepsy Schedule (MIOES), 1b.Impact of Childhood Illness Scale (ICI), 2.The Hague Restrictions in Childhood Epilepsy Scale (HARCES), 3.Quality of Life in Epilepsy Inventory for Adolescents (QOLIE-AD-48), 4.Quality of Life in
Pediatric Epilepsy (QOLPES),5a-5d.Quality of Life in Childhood Epilepsy (QOLCE), 6.Impact of Pediatric Epilepsy Scale (IPES), 7.Health-Related Quality of LifeMeasure for Childrenwith Epilepsy (CHEQOL-25), 8.DISABKIDS EpilepsyModule, 9.Epilepsy
and Learning Disability Quality of Life (ELDQOL), 10.Glasgow Epilepsy Outcome Scale (GEOS-YP), 11.PEDSQL Epilepsy Module.
a The ICI has a ‘frequency’ scale and an ‘importance’ scale. The importance scale asks about the impact of all these questions on parental health.
b The MIoES assesses parental worry about each question.
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Table 4
Number of items from 11 epilepsy-specific PROMs for children represented in the 10 domains of a proposed core outcome set for childhood epilepsy.
1a. MIoES
(39)
1b. ICI
(30)
2.
HARCES
(10)
3.
QOLIE-AD-48
(48)
4a. QOLPES
-Parent
(20)
4b. QOLPES
-Child
(20)
5a.
G-QOLCE
5b.
QOLCE-76
(76)
5c.
QOLCE-55
(55)
5d.
QOLCE-16
(16)
6.
IPES
(11)
7a. CHEQOL
-Child
(25)
7b.
CHEQOL-Parent
(25)
8.
DISABKIDs
(10)
9.
ELDQOL
(44)
10.
GEOS-YP
(45)
11.
PEDSQL
(28)
SEIZURES – – – – – – – – – – – – – – 14 (32%) 4 (9%) –
SLEEP – – – – – – – – – – – – – – 1 (2%) – 3 (11%)
PHYSICAL
FUNCTIONING
– – 4 (40%) 4 (8%) 1 (5%) 1 (5%) – 9 (12%) 5 (9%) 3 (19%) – – – – 3 (7%) 1 (2%) 1 (4%)
SOCIAL
FUNCTIONING
2 (5%) 2 (7%) 3 (30%) 2 (4%) 2 (10%) 2 (10%) – 9 (12%) 8 (15%) 4 25% 2
(18%)
7 (28%) 4 (16%) – 1 (2%) 6 (13%) 1 (4%)
BEHAVIOR 3 (8%) – – 2 (4%) 1 (5%) – – 8 (11%) 6 (11%) – – – – – 1 (2%) – 2 (7%)
MENTAL HEALTH 2 (5%) 2 (7%) – 13 (27%) 1 (5%) 5 (25%) – 18 (24%) 9 (16%) 4 25% 1
(9%)
10 (40%) 9 (36%) 10 (100%) 1 (2%) 13 (29%) 8 (29%)
COGNITION 3 (8%) 2 (7%) – 12 25% 2 (10%) 3 (15%) – 20 (26%) 22 40% 4 25% 1
(9%)
2 (8%) 2 (8%) – 3 (7%) 2 (4%) 6 (21%)
FAMILY
FUNCTIONING
19 (49%) 8 (27%) – 1 (2%) 5 (25%) 1 (5%) – 1 (1%) – – 4
(36%)
1 (4%) – – 4 (9%) – –
ADVERSE EVENTS – 2 (7%) – – – – – – – – – – – – 2 (5%) 1 (2%) –
GLOBAL QUALITY
OF LIFE
– – – – 1 (5%) 1 (5%) 1 (100%) 1 (1%) – – 1
(9%)
1 (4%) – – 1 (2%) – –
OTHER/DOES NOT
FIT TO COS
10 (26%) 14 (47%) 3 (30%) 14 (29%) 7 (35%) 7 (35%) – 10 (13%) 5 (9%) 1 (6%) 2
(18%)
4 (16%) 10 (40%) – 13 (30%) 18 (40%) 7 (25%)
1a. Modified Impact of Epilepsy Schedule (MIOES), 1b.Impact of Childhood Illness Scale (ICI), 2.The Hague Restrictions in Childhood Epilepsy Scale (HARCES), 3.Quality of Life in Epilepsy Inventory for Adolescents (QOLIE-AD-48), 4.Quality of Life in
Pediatric Epilepsy (QOLPES),5a-5d.Quality of Life in Childhood Epilepsy (QOLCE), 6.Impact of Pediatric Epilepsy Scale (IPES), 7.Health-RelatedQuality of LifeMeasure for Childrenwith Epilepsy (CHEQOL-25), 8.DISABKIDS EpilepsyModule, 9.Epilepsy
and Learning Disability Quality of Life (ELDQOL), 10.Glasgow Epilepsy Outcome Scale (GEOS-YP), 11.PEDSQL Epilepsy Module.
Bracket underneath the PROM name indicates the number of items in the PROM.
Percentage underneath item number has been rounded to 1 decimal place.
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9H. Crudgington et al. / Epilepsy & Behavior 112 (2020) 107372across four domains (Cognitive; Emotional; Social; Physical). The ques-
tions ask the respondent to rate on a 6-point Likert-scale (Very Often,
Fairly Often, Sometimes, Almost Never, Never, Not applicable) how often
during the past four weeks the respondent's child has done something
e.g., had trouble remembering things. The QOLCE-55 is a shortened ver-
sion of the QOLCE-76. The items of the QOLCE-76 were derived from a
focus group of patients with epilepsy [20,21].
Advisory Panel parents completed the QOLCE-55 in 3–7 min. The
questionnaire was deemed easy to understand with clear instructions.
One question that was difficult to understand for one parent was ‘how
often has your child been able to do physical activities other children his/
her age do?’. It was suggested that “activities” is a broad concept that
could be broken down into specific activities to make the question eas-
ier to answer. Some questions asked about ‘how your child feels’, and
parents commented that for some questions you can intuit an answer,
but for other more subjective questions about feelings their answer
may not be an accurate reflection of their child's feelings.
3.2.2. CHEQOL
The CHEQOL has child self-report and parent proxy report versions
for children with epilepsy aged between 6 and 15 years old. It has 25
items across five domains (Interpersonal/Social consequences; Worries
and concerns; Intrapersonal/Emotional Issues; Epilepsy My Secret;
Quest for Normality). The items are presented as two polar statements
such as ‘some kids with epilepsy say kids won't play with them’ and
‘other kids with epilepsy say other kids always play with them’. The child
or parent respondent is asked to decide which statement is ‘most like
them’ by circling it and to also decide if this is ‘really true’ or ‘sort of
true’ by ticking a box. The items of the CHEQOL were developed using
focus group discussions involving children with epilepsy and their
parents [60]. Parents from our Advisory Panel completed CHEQOL in
4–9 min and children from our Advisory Panel completed CHEQOL in
15–18min. The parent and child version ask mostly the same questions
except for questions about the future, driving a car and jobs, which are
only in the parent version.
One Advisory Panel parent commented that the two different state-
ments e.g., ‘some kids with epilepsy say kidswon't playwith them’ seemed
to be ‘pessimistic’ and ‘other kids with epilepsy say other kids always play
with them’ seemed to be ‘optimistic’ indicating that choosing a response
option may not be a straightforward decision depending on the
respondent's viewpoint. The statements were deemed appropriate but
there was no context to the questionnaire such as the recall period
(e.g., over the last week) for answering the questions, and the questions
referred to an abstract child.
Children commented that they ‘liked’ the CHEQOL and the content of
questions. One child from the Advisory Panel stated that the question
about ‘medication’ should have a ‘not applicable’ option. The response
options of ‘some kids’ and ‘other kids’ could be ‘confusing’ at times.
3.2.3. Comparing QOLCE-55 and CHEQOL
For parents in our Advisory Panel, the QOLCE-55 questionnaire was
preferable to the CHEQOL. Parents found that the QOLCE-55 items and
response options were in a recognizable Likert style format. All parents
commented that the CHEQOL asked important and relevant questions
about epilepsy, but the response options that ask about an abstract
child could be confusing to interpret. Overall, our consultation suggests
that CHEQOLwas acceptable to childrenwith epilepsy and their parents
and QOLCE-55 is acceptable to parents.
4. Discussion
We have described how the content of 11 epilepsy-specific PROMs
of children's HRQoL map to the 10 domains and 38 discrete outcomes
of our proposed COS. Our COS items have been prioritized as most im-
portant to measure by children with epilepsy, their parents, and profes-
sionals in the UK [11]. All 11 PROMs (17 questionnaire versions) cover arange of our COS outcomes but none cover them all. Most PROMs cover
aspects of Social Functioning and Mental Health, while others neglect
items on Seizures or Sleep. Members of our Advisory Panel found the
two leading PROMs from our prior systematic review, QOLCE-55 (par-
ent-report) and CHEQOL (parent and child report), to be acceptable
for research use in the context of the UK National Health Service (NHS).
The PROMsmeasure a subjective perception of health, wellbeing, and
QOL, and they constitute one of several available evaluative tools.
Hence, although only two PROMs mapped to the Seizure domain, sei-
zures might be more appropriately measured objectively using video-
electroencephalography, or more systematically using a specific rating
scale. Similarly, Cognition andMental health could be measured using a
variety of domain-specific and well-validated instruments. Therefore,
it is not appropriate to judge the HRQoL PROMs on how well they fit
to our COS, which contains outcomes and domains that may be better
measured in other ways.
At the same time, some PROM itemswere notmapped to our COS as
they did not fit within its conceptual framework e.g., items reflecting
independence, future concerns, or worries. The COS development is a
method of defining which outcomes are of most importance to stake-
holders, but it does not mean that other outcomes may not also be im-
portant to measure. We are not suggesting that a new PROM should be
developed that is inclusive of all domains of our proposed COS, or that
the extent to which a PROM measures the domains makes it ‘better’
than others. Rather, we are promoting the uptake of our COS as a frame-
work for selecting outcomes and PROMs for childhood epilepsy re-
search, not as a rigid set of outcomes to be measured.
Mapping to our COS is an important step for childhood epilepsy re-
search as our COS is unique in its representation of stakeholders'
views, unlike other tools and frameworks [12–15]. The COS outcomes
were decided through a transparent process using Delphi methodology
that avoids overinfluence of one type of stakeholder (youngpersonwith
epilepsy vs parent vs professional) over another [11]. Our COS includes
child-centered outcomes such as school attendance, concealment, and re-
lationship with parent and siblings that are not solely seizure or health-
focused, highlighting how important it is to measure outcomes that
are relevant and of concern to children with epilepsy. Although unique,
our COSmapping is a useful adjunct to the Sadeghi et al. [8] analysis that
mapped the items of epilepsy-specific PROMs to the ICF-CY framework
and also made clear their biopsychosocial content. Sadeghi et al. found
that regardless of the PROM title, most of the PROMs measured
biopsychosocial health, as opposed to a subjective assessment of health
(HRQoL) or a subjective perception about the respondent's life (QoL). To
measure outcomes validly in research, it is essential to utilize a PROM
that conceptually matches the outcome(s) of interest, otherwise, it
could result in a study falsely concluding an intervention is ineffective.
We highlighted CHEQOL and QOLCE-55 as leading PROMs because
they measured salient items from our COS and have robust measure-
ment properties. Both CHEQOL and QOLCE-55 are north American
PROMS that cover a range of our COS domains, with considerable over-
lap. They have more emphasis on the domains of Mental Health and
Social Functioning. To our knowledge, both the QOLCE-55 and CHEQOL
PROMs have not been mapped to any other kind of framework except
for the ICF-CY. The QOLCE-55 belongs to the QOLCE PROM family that
consists of four questionnaire versions with different numbers of
items (QOLCE-76, QOLCE-55, QOLCE-16, and G-QOLCE) [19–25]. Of all
the versions, the QOLCE-55 questionnaire has good and replicated evi-
dence for structural and construct validity and internal consistency
[22,23]. In comparison, the CHEQOL questionnaire has both child
(aged 6–15 years) and parent-reported versions and good evidence of
content, structural, and construct validity [18].
Acceptability is an essential property of a PROM as it is important
that items do not cause distress, are relevant and important, and re-
spondents can easily complete it [7]. The acceptability test is an essential
final feasibility step in deciding how to measure an outcome, once the
outcomes of interest and candidate instruments have been decided.
10 H. Crudgington et al. / Epilepsy & Behavior 112 (2020) 107372The items of the QOLCE were derived from a focus group of patients
with epilepsy [20], and professionals reviewed the questionnaire for
content and clarity. Similarly, the items of the CHEQOL were developed
using focus group discussions involving childrenwith epilepsy and their
parents [60]. The QOLCE and CHEQOL versions have also been used in-
ternationally for numerous evaluative studies and have been translated
into other languages [25–50]. However, although the itemdevelopment
work involved relevant stakeholders, it is not clear if further validation
work looked at the ‘real-life’use of a PROMsuch as the time to complete,
or if other studies that translated the PROMs had further assessed their
acceptability. Our Advisory Panel members considered both CHEQOL
and QOLCE-55 to be acceptable for real-life use in a UK context.
Patient and Public Involvement and Engagement in health research
is becoming increasingly important to make sure that research is as rel-
evant and useful as possible to patients [52]. It is less concernedwith the
methods used to seek people's views and more about what PPIE mem-
bers are asked to contribute, what recommendations they make and,
importantly, what action is taken in response. Consulting Advisory
Panels on the acceptability of a PROM to clarify any misunderstandings
could lead to a considerable impact on the future research use of the
PROM such as during scoring and analysis. For example, Love et al.
[45] found when using the QOLCE in an evaluative study on children
with epilepsy that the ‘Not Applicable (N/A)’ box resulted in missing
data. Love et al. suggest that this could be due to the different interpre-
tation of ‘N/A’ between parent respondents and from clinicians, e.g., par-
entsmay tick ‘N/A’ because their child does not engage in that behavior,
whereas a clinician could argue that ‘0’would be the better item scoring.
The QOLCE-55 is a shorter version of the QOLCE, and so does not include
all the items of the QOLCE 76. However, the ‘N/A’ is still an item scoring
option and it is important to consider. Parents in our Advisory Panel
found the ‘N/A’ option useful, but it needs to be ensured that respon-
dents fully understand how to answer the questions to avoid missing
data and misinterpretation of items and their scoring. Our Advisory
Panel's comments about the familiarity of the Likert rating for the
QOLCE-55, and parents' lack of confidence in intuiting their child's feel-
ings, are valuable insights to aid researchers or clinicians inmakingfinal
decisions about deploying an instrument.
4.1. Conclusion
When decidingwhich PROM to use for a specific purpose, it is essen-
tial to consider (a) matching the implicit conceptual framework to the
outcomes of research interest; (b) robust evidence of measurement
properties; and (c) the appropriateness and acceptability of the ques-
tionnaire and individual questions to the respondents in the same con-
text that the research will be conducted. We recommend researchers
consult with families in the context of PPIE to ensure measures are ac-
ceptable for their settings and their research questions. In our case,
both QOLCE-55 (parent-report) and CHEQOL (parent and child report)
were considered acceptable and mapped well to our COS. This exercise
was an important first step in applying our recently developed COS as a
framework for selecting outcomes for evaluative research in childhood
epilepsy in the UK.
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